Core C Clinical Trials Core: The function of Core C is to facilitate the translation of laboratory findings into the necessary clinical and correlative studies. This Clinical Trials Core provides the support and resources for activation, conduct and completion of the clinical trials or clinically-related aspects of each of the projects. This Core will provide the infrastructure so that concepts emanating from the projects can be evaluated for translational suitability, formulated into appropriate clinical protocols that will be carried out with the appropriate regulatory oversight, safety and collection of clinical data. This core is a necessary and vital component of the SARC Sarcoma SPORE and will streamline and standardize interaction with the clinical trial infrastructure of forty sarcoma clinical trials centers across the United States. The success of SARC is significantly based upon an outstanding record of accomplishment of designing, conducting and analyzing clinical trials in patients with sarcoma. SARC Clinical Trials Core leadership under the direction of Laurence Baker is experienced in facilitating multi-center research.

Public Health Relevance

Currently there are limited programs that have the capabilities to provide the infrastructure for collaboration on clinical trial research for sarcoma. Because sarcoma is a relatively uncommon disease and that it occurs across the human like span, this clinical trial Core will provide the infrastructure to facilitate the conduct of clinical research to identify new beneficial treatment options for patients with sarcoma.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
1U54CA168512-01
Application #
8395580
Study Section
Special Emphasis Panel (ZCA1-RPRB-7 (M1))
Project Start
2012-09-26
Project End
2017-08-31
Budget Start
2012-09-26
Budget End
2013-08-31
Support Year
1
Fiscal Year
2012
Total Cost
$181,063
Indirect Cost
$9,998
Name
Sarc
Department
Type
DUNS #
186146911
City
Ann Arbor
State
MI
Country
United States
Zip Code
48106
Choy, Edwin; Ballman, Karla; Chen, James et al. (2018) SARC018_SPORE02: Phase II Study of Mocetinostat Administered with Gemcitabine for Patients with Metastatic Leiomyosarcoma with Progression or Relapse following Prior Treatment with Gemcitabine-Containing Therapy. Sarcoma 2018:2068517
Yu, Peter Y; Lopez, Gonzalo; Braggio, Danielle et al. (2018) miR-133a function in the pathogenesis of dedifferentiated liposarcoma. Cancer Cell Int 18:89
Ignatius, Myron S; Hayes, Madeline N; Moore, Finola E et al. (2018) tp53 deficiency causes a wide tumor spectrum and increases embryonal rhabdomyosarcoma metastasis in zebrafish. Elife 7:
Hawkins, Allegra G; Basrur, Venkatesha; da Veiga Leprevost, Felipe et al. (2018) The Ewing Sarcoma Secretome and Its Response to Activation of Wnt/beta-catenin Signaling. Mol Cell Proteomics 17:901-912
Barrott, Jared J; Zhu, Ju-Fen; Smith-Fry, Kyllie et al. (2017) The Influential Role of BCL2 Family Members in Synovial Sarcomagenesis. Mol Cancer Res 15:1733-1740
Ignatius, Myron S; Hayes, Madeline N; Lobbardi, Riadh et al. (2017) The NOTCH1/SNAIL1/MEF2C Pathway Regulates Growth and Self-Renewal in Embryonal Rhabdomyosarcoma. Cell Rep 19:2304-2318
Kadoch, Cigall; Williams, Robert T; Calarco, Joseph P et al. (2017) Dynamics of BAF-Polycomb complex opposition on heterochromatin in normal and oncogenic states. Nat Genet 49:213-222
Hayashi, Masanori; Baker, Alissa; Goldstein, Seth D et al. (2017) Inhibition of porcupine prolongs metastasis free survival in a mouse xenograft model of Ewing sarcoma. Oncotarget 8:78265-78276
Alomari, Ahmed K; Brown, Noah; Andea, Aleodor A et al. (2017) Cutaneous syncytial myoepithelioma: A recently described neoplasm which may mimic nevoid melanoma and epithelioid sarcoma. J Cutan Pathol 44:892-897
Svoboda, Laurie K; Bailey, Natashay; Van Noord, Raelene A et al. (2017) Tumorigenicity of Ewing sarcoma is critically dependent on the trithorax proteins MLL1 and menin. Oncotarget 8:458-471

Showing the most recent 10 out of 111 publications